GO:0046370 fructose biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046370 fructose biosynthetic process describes the chemical reactions and pathways that result in the formation of fructose, the ketohexose arabino-2-hexulose.
• Fructose biosynthesis is not a single linear pathway; it involves gluconeogenic and polyol pathway enzymes that generate fructose from glucose or sorbitol precursors.
• The small intestine plays a major role in fructose metabolism, converting dietary fructose into glucose and organic acids, thereby shielding the liver from excessive fructose exposure.
• Dysregulated fructose production and metabolism are linked to metabolic syndrome, non-alcoholic fatty liver disease, kidney injury, and cancer.
• Key enzymes include aldose reductase (AKR1B1), sorbitol dehydrogenase (SORD), ketohexokinase (KHK), and fructose-1,6-bisphosphatase (FBP1), which collectively regulate fructose synthesis and breakdown.
• CRISPR-based models (knockout, knock-in, overexpression) are essential for dissecting the causal roles of fructose biosynthetic genes in health and disease.
Description
Fructose biosynthetic process (GO:0046370) is defined as the chemical reactions and pathways resulting in the formation of fructose, the ketohexose arabino-2-hexulose. While fructose is best known as a dietary sugar, it can also be synthesized endogenously from glucose via the polyol pathway, particularly in tissues such as the kidney, liver, and small intestine. This process is critical for maintaining fructose homeostasis and for providing fructose for metabolic needs when dietary intake is low. Understanding fructose biosynthesis is important because its dysregulation contributes to metabolic disorders, including obesity, insulin resistance, and fatty liver disease. Recent studies have highlighted the small intestine as a key site of fructose metabolism, where it converts dietary fructose into glucose and organic acids, thereby limiting fructose delivery to the liver and preventing steatosis. In cancer, fructose metabolism supports tumor growth and proliferation, making enzymes of fructose biosynthesis potential therapeutic targets. This article integrates authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of GO:0046370, its genetic players, regulatory mechanisms, disease relevance, and experimental models for research.
fructose biosynthetic process At A Glance
| GO ID | GO:0046370 |
|---|---|
| GO term | fructose biosynthetic process |
| Ontology | biological_process |
| Synonym | fructose anabolism; fructose biosynthesis; fructose formation; fructose synthesis |
| Major function | Endogenous production of fructose from glucose or sorbitol precursors |
| Key enzymes | AKR1B1, SORD, KHK, FBP1, ALDOB |
| Tissue distribution | Liver, kidney, small intestine, adipose tissue |
| Related pathways | Polyol pathway, gluconeogenesis, fructose metabolism |
What Is GO:0046370?
The fructose biosynthetic process (GO:0046370) encompasses the enzymatic steps that lead to the production of fructose from precursor molecules. In the polyol pathway, glucose is first reduced to sorbitol by aldose reductase (AKR1B1), and sorbitol is then oxidized to fructose by sorbitol dehydrogenase (SORD). Alternatively, fructose can be generated through gluconeogenic intermediates, such as fructose-6-phosphate, which is dephosphorylated to free fructose by specific phosphatases. This process is distinct from fructose catabolism, which breaks down fructose for energy. The QuickGO definition emphasizes the formation of fructose, the ketohexose arabino-2-hexulose, and includes synonyms such as fructose anabolism, fructose biosynthesis, fructose formation, and fructose synthesis.
Why Is fructose biosynthetic process Important in Cell Biology?
Fructose biosynthetic process is important because endogenous fructose production contributes to total fructose load and can exacerbate metabolic diseases when overactivated. In the kidney, fructose production via the polyol pathway is implicated in diabetic nephropathy and kidney injury. In the small intestine, fructose metabolism protects the liver from fructose-induced steatosis, highlighting a tissue-specific role for fructose biosynthetic and catabolic enzymes. Moreover, cancer cells often upregulate fructose metabolism to support growth, making this pathway a potential target for anticancer therapy. Thus, understanding GO:0046370 is essential for researchers studying metabolism, diabetes, obesity, and cancer.
• Endogenous fructose production via the polyol pathway contributes to hyperglycemia-induced complications in diabetes.
• The small intestine converts dietary fructose into glucose and organic acids, limiting hepatic fructose exposure and steatosis.
• Fructose metabolism is reprogrammed in cancer cells to support proliferation and survival.
• Dietary fructose overconsumption is linked to metabolic syndrome, insulin resistance, and non-alcoholic fatty liver disease.
• Fructose production in the kidney is associated with diabetic nephropathy and renal injury.
• Fructose overconsumption can reprogram microglia metabolism and function, implicating neuroinflammation.
• Fructose-sorbitol malabsorption is a clinical condition affecting gastrointestinal function.
• Enzymes of fructose biosynthesis are potential drug targets for metabolic disorders and cancer.
What Happens During fructose biosynthetic process?
Uptake of glucose and initiation of the polyol pathway
In simple terms: Glucose enters cells and is converted to sorbitol by aldose reductase.
The first step in one major route of fructose biosynthesis is the reduction of glucose to sorbitol by aldose reductase (AKR1B1), an NADPH-dependent enzyme. This step occurs in tissues such as the kidney, lens, and nerve cells, and is particularly active under hyperglycemic conditions. The polyol pathway is a major source of endogenous fructose, especially when glucose levels are high.
Oxidation of sorbitol to fructose
In simple terms: Sorbitol is then converted to fructose by sorbitol dehydrogenase.
Sorbitol dehydrogenase (SORD) oxidizes sorbitol to fructose using NAD+ as a cofactor. This reaction completes the polyol pathway and generates free fructose, which can then enter glycolysis or other metabolic routes. In the kidney, this pathway contributes to fructose accumulation and associated cellular stress.
Gluconeogenic production of fructose-6-phosphate
In simple terms: Fructose can also be made from glucose through gluconeogenesis.
In the liver and kidney, gluconeogenesis produces fructose-6-phosphate from non-carbohydrate precursors. Fructose-6-phosphate can be dephosphorylated to free fructose by specific phosphatases, although this step is less characterized. The small intestine also contributes to fructose metabolism by converting fructose to glucose and organic acids, which can indirectly affect fructose biosynthesis.
Fructose phosphorylation and cleavage
In simple terms: Fructose is phosphorylated by ketohexokinase and then split into smaller molecules.
Fructose is phosphorylated to fructose-1-phosphate by ketohexokinase (KHK). Fructose-1-phosphate is then cleaved by aldolase B (ALDOB) into dihydroxyacetone phosphate and glyceraldehyde, which enter glycolysis or gluconeogenesis. This step is crucial for fructose catabolism and is often upregulated in cancer.
Regulation by fructose-1,6-bisphosphatase
In simple terms: FBP1 controls a key step in gluconeogenesis that affects fructose production.
Fructose-1,6-bisphosphatase (FBP1) catalyzes the conversion of fructose-1,6-bisphosphate to fructose-6-phosphate, a rate-limiting step in gluconeogenesis. FBP1 activity influences the availability of fructose-6-phosphate for fructose biosynthesis. Loss of FBP1 in cancer promotes glycolysis and biosynthetic pathways, including fructose metabolism.
Key Genes Involved in GO:0046370 fructose biosynthetic process
The following genes encode enzymes and transporters directly involved in fructose biosynthetic process and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AKR1B1 | Aldose reductase; reduces glucose to sorbitol in the polyol pathway | Target for diabetic complications; linked to kidney injury |
| SORD | Sorbitol dehydrogenase; oxidizes sorbitol to fructose | Key enzyme in endogenous fructose production; implicated in kidney disease |
| KHK | Ketohexokinase; phosphorylates fructose to fructose-1-phosphate | Central to fructose metabolism; upregulated in cancer |
| ALDOB | Aldolase B; cleaves fructose-1-phosphate into DHAP and glyceraldehyde | Mutations cause hereditary fructose intolerance; role in cancer |
| FBP1 | Fructose-1,6-bisphosphatase; regulates gluconeogenesis and fructose-6-phosphate levels | Tumor suppressor; loss promotes cancer metabolism |
| SLC2A2 | GLUT2; facilitates glucose and fructose transport | Important for fructose uptake in liver and intestine |
| SLC2A5 | GLUT5; primary fructose transporter in intestine and kidney | Mediates dietary fructose absorption |
| SLC5A1 | SGLT1; sodium-glucose cotransporter; also transports fructose | Contributes to fructose uptake in small intestine |
| GCK | Glucokinase; phosphorylates glucose to glucose-6-phosphate | Upstream of glycolysis and fructose biosynthesis |
| PFKL | Phosphofructokinase, liver type; regulates glycolysis | Affects fructose-6-phosphate availability |
| TPI1 | Triosephosphate isomerase; interconverts DHAP and G3P | Downstream of fructose cleavage |
| G6PD | Glucose-6-phosphate dehydrogenase; generates NADPH for polyol pathway | Supports aldose reductase activity |
| AKR1A1 | Aldehyde reductase; can also reduce glucose to sorbitol | Alternative enzyme for sorbitol production |
| TXN | Thioredoxin; regulates redox state | May influence polyol pathway activity |
| NFE2L2 | Nrf2; transcription factor regulating antioxidant genes | Modulates oxidative stress in fructose metabolism |
| PPARA | Peroxisome proliferator-activated receptor alpha; regulates lipid metabolism | Linked to fructose-induced steatosis |
| SREBF1 | Sterol regulatory element-binding transcription factor 1; controls lipogenesis | Activated by fructose, promoting fatty liver |
| MLXIPL | ChREBP; carbohydrate-responsive element-binding protein | Mediates fructose-induced lipogenesis |
How Is fructose biosynthetic process Regulated?
Fructose biosynthetic process is regulated at multiple levels. The polyol pathway enzymes AKR1B1 and SORD are induced under hyperglycemic conditions, increasing endogenous fructose production. In the small intestine, fructose metabolism is regulated by the availability of fructose transporters such as GLUT5 and GLUT2. Hormonal signals, including insulin and glucagon, influence gluconeogenic flux and thus fructose-6-phosphate availability. Transcription factors such as ChREBP (MLXIPL) and SREBP-1c (SREBF1) are activated by fructose and promote lipogenic gene expression, linking fructose metabolism to lipid synthesis. In cancer, oncogenic pathways such as PI3K/AKT and MYC can upregulate fructose metabolism enzymes, including KHK and ALDOB. Additionally, oxidative stress and inflammatory signals modulate polyol pathway activity in kidney and microglia.
fructose biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AKR1B1 | Diabetic nephropathy, kidney injury | Knockout mouse; overexpression in renal cells |
| SORD | Diabetic complications, cataract | Point mutation knock-in; KO in lens cells |
| KHK | Cancer, metabolic syndrome | KO and overexpression in cancer cell lines |
| ALDOB | Hereditary fructose intolerance, cancer | Knock-in of patient mutations; KO in hepatocytes |
| FBP1 | Cancer, hypoglycemia | Knockout in cancer cells; overexpression in liver |
Fructose biosynthesis in metabolic syndrome and fatty liver disease
Excessive fructose production and consumption contribute to metabolic syndrome, insulin resistance, and non-alcoholic fatty liver disease (NAFLD). Fructose bypasses the phosphofructokinase regulatory step and provides unregulated carbon for lipogenesis, leading to hepatic steatosis. The small intestine plays a protective role by converting fructose to glucose and organic acids, but this capacity can be overwhelmed by high fructose intake. Endogenous fructose production via the polyol pathway also contributes to hyperglycemia-induced complications in diabetes.
Fructose metabolism in cancer
Cancer cells often reprogram fructose metabolism to support rapid growth. Upregulation of KHK and ALDOB enhances fructose utilization, while loss of FBP1 promotes glycolysis and biosynthetic pathways. Fructose can also be generated endogenously in cancer cells through the polyol pathway, contributing to tumor progression. Targeting fructose biosynthetic enzymes is being explored as a therapeutic strategy.
Fructose production in kidney disease
The kidney is a major site of endogenous fructose production via the polyol pathway. Under hyperglycemic conditions, increased aldose reductase activity leads to sorbitol and fructose accumulation, causing osmotic and oxidative stress. This contributes to diabetic nephropathy and renal injury. Inhibitors of the polyol pathway are being investigated for kidney protection.
Fructose overconsumption and neuroinflammation
Fructose overconsumption can reprogram microglial metabolism and function, promoting neuroinflammation. This suggests a link between fructose metabolism and neurodegenerative processes. However, the role of endogenous fructose biosynthesis in the brain remains to be fully elucidated.
From fructose biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does AKR1B1 knockout reduce endogenous fructose production? | AKR1B1 knockout cell line (e.g., HEK293) |
| Does SORD point mutation affect sorbitol dehydrogenase activity? | SORD point-mutation knock-in via CRISPR |
| Can KHK overexpression enhance fructose metabolism in cancer? | KHK overexpression in cancer cell lines |
| Does FBP1 loss promote fructose biosynthesis? | FBP1 knockout in hepatocytes |
| Does tagged ALDOB localize to specific cellular compartments? | Tagged knock-in of ALDOB with GFP |
| Does GLUT5 overexpression increase fructose uptake? | SLC2A5 overexpression in intestinal cells |
How to Study the fructose biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Fructose, sorbitol, and pathway intermediates | Quantify endogenous fructose production |
| 13C isotope tracing | Flux through fructose biosynthetic pathways | Determine carbon sources for fructose |
| RNA-seq | Gene expression changes | Identify transcriptional regulators |
| Western blot | Protein levels of AKR1B1, SORD, KHK | Validate CRISPR models |
| Enzyme activity assay | Aldose reductase and SORD activity | Functional validation of mutations |
| CRISPR knockout screen | Genes essential for fructose metabolism | Discover novel targets |
| Immunofluorescence | Subcellular localization of enzymes | Study compartmentalization |
| Seahorse assay | Glycolytic and oxidative metabolism | Measure metabolic reprogramming |
Metabolomics and flux analysis
Metabolomics using mass spectrometry can quantify fructose, sorbitol, and intermediates of the polyol and gluconeogenic pathways. Isotope tracing with 13C-labeled glucose or fructose allows measurement of flux through fructose biosynthetic pathways. These methods are essential for determining the contribution of endogenous fructose production to total fructose pools.
RNA-seq and transcriptomics
RNA sequencing can identify genes differentially expressed during fructose biosynthesis, including AKR1B1, SORD, KHK, and ALDOB. Transcriptomic profiling of tissues such as liver, kidney, and small intestine reveals tissue-specific regulation. This approach helps uncover transcriptional networks controlled by ChREBP and SREBP-1c.
Proteomics and enzyme activity assays
Proteomic analysis can quantify protein levels of fructose biosynthetic enzymes. Enzyme activity assays for aldose reductase and sorbitol dehydrogenase measure functional changes in response to genetic or pharmacological perturbations. These assays are critical for validating CRISPR knockout or knock-in models.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for fructose biosynthesis and metabolism. Pooled screens with fructose as the sole carbon source can uncover synthetic lethal interactions. These functional genomics approaches accelerate target discovery in cancer and metabolic diseases.
How CRISPR Can Be Used to Study GO:0046370 fructose biosynthetic process
Knockout
CRISPR knockout of genes such as AKR1B1, SORD, KHK, or ALDOB can abolish specific steps in fructose biosynthesis. These models are used to determine the contribution of each enzyme to endogenous fructose production and to assess metabolic phenotypes. Knockout cell lines are also valuable for drug target validation.
Point Mutation
Point mutations in SORD or ALDOB can mimic human disease variants, such as those causing hereditary fructose intolerance. CRISPR point-mutation knock-in allows precise modeling of enzyme deficiencies and structure-function studies. These models help elucidate the impact of specific amino acid changes on fructose biosynthesis.
Knock-in
Knock-in of tagged versions of enzymes (e.g., GFP-ALDOB) enables live-cell imaging and protein interaction studies. Knock-in of reporter genes under the control of endogenous promoters can track fructose biosynthetic gene expression. This approach is useful for studying dynamic regulation in real time.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can increase expression of genes like KHK or GLUT5 to enhance fructose metabolism. Overexpression models are used to study the consequences of elevated fructose biosynthesis in cancer and metabolic cells. These models complement knockout studies by providing gain-of-function insights.
How EDITGENE Supports fructose biosynthetic process Research
Researchers studying fructose biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in fructose production, metabolic reprogramming, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes in the fructose biosynthetic pathway.
Contact EDITGENE today to design your custom CRISPR model for fructose biosynthetic process research.
Frequently Asked Questions About fructose biosynthetic process
What is fructose biosynthetic process (GO:0046370)?
It is the set of chemical reactions and pathways that produce fructose, the ketohexose arabino-2-hexulose, from precursors such as glucose or sorbitol.
What genes are involved in fructose biosynthetic process?
Key genes include AKR1B1, SORD, KHK, ALDOB, FBP1, SLC2A2, SLC2A5, and SLC5A1, which encode enzymes and transporters in the polyol and gluconeogenic pathways.
How is fructose produced endogenously?
Endogenous fructose is produced via the polyol pathway, where glucose is reduced to sorbitol by aldose reductase and then oxidized to fructose by sorbitol dehydrogenase.
What is the role of the small intestine in fructose metabolism?
The small intestine converts dietary fructose into glucose and organic acids, limiting fructose delivery to the liver and protecting against steatosis.
Is fructose biosynthesis linked to cancer?
Yes, cancer cells often upregulate fructose metabolism, including enzymes like KHK and ALDOB, to support growth and proliferation.
What diseases are associated with fructose biosynthetic process?
Dysregulation is linked to metabolic syndrome, non-alcoholic fatty liver disease, diabetic nephropathy, and cancer.
How can CRISPR be used to study fructose biosynthesis?
CRISPR knockout, knock-in, point mutation, and overexpression models allow functional dissection of genes like AKR1B1, SORD, and KHK in fructose production.
What methods measure fructose biosynthetic flux?
Metabolomics, isotope tracing, and enzyme activity assays are commonly used to quantify fructose and pathway intermediates.
What is the polyol pathway?
The polyol pathway is a two-step metabolic route that converts glucose to sorbitol and then to fructose, contributing to endogenous fructose production.
Why is fructose biosynthesis important in diabetes?
In diabetes, hyperglycemia increases polyol pathway flux, leading to fructose accumulation and cellular stress in tissues like kidney and lens.
Conclusion
Fructose biosynthetic process (GO:0046370) is a fundamental metabolic pathway that generates fructose from glucose or sorbitol, with critical roles in normal physiology and disease. The polyol pathway and gluconeogenic routes contribute to endogenous fructose production, and their dysregulation is implicated in metabolic syndrome, fatty liver disease, kidney injury, and cancer. The small intestine acts as a key metabolic barrier, converting fructose to glucose and organic acids to protect the liver. Advances in CRISPR-based models and metabolomic technologies are enabling precise dissection of the genetic and biochemical control of fructose biosynthesis. EDITGENE provides comprehensive services to support this research, from knockout and knock-in cell models to CRISPR library screening and bioinformatics.
References
- 1. Softic S et al.. 2016. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.. Dig Dis Sci 61(5):1282-93 PMID: 26856717
- 2. Jang C et al.. 2018. The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids.. Cell Metab 27(2):351-361.e3 PMID: 29414685
- 3. Krause N et al.. 2020. Fructose Metabolism in Cancer.. Cells 9(12) PMID: 33302403
- 4. Fernández-Bañares F et al.. 2009. Fructose-sorbitol malabsorption.. Curr Gastroenterol Rep 11(5):368-74 PMID: 19765364
- 5. Jang C et al.. 2020. The small intestine shields the liver from fructose-induced steatosis.. Nat Metab 2(7):586-593 PMID: 32694791
- 6. Taskinen MR et al.. 2019. Dietary Fructose and the Metabolic Syndrome.. Nutrients 11(9) PMID: 31443567
- 7. Nakagawa T et al.. 2020. Fructose Production and Metabolism in the Kidney.. J Am Soc Nephrol 31(5):898-906 PMID: 32253274
- 8. Ting KKY. 2024. Fructose overconsumption-induced reprogramming of microglia metabolism and function.. Front Immunol 15:1375453 PMID: 38596671
